NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease

Diabetes mellitus is the leading cause of cardiovascular and renal disease in the United -States. Despite the beneficial interventions available for patients with diabetes, there remains a need for additional therapeutic targets and therapies in diabetic kidney disease (DKD). Inflammation and oxidat...

Descripción completa

Detalles Bibliográficos
Autores principales: Myakala, Komuraiah, Wang, Xiaoxin X., Shults, Nataliia V., Krawczyk, Ewa, Jones, Bryce A., Yang, Xiaoping, Rosenberg, Avi Z., Ginley, Brandon, Sarder, Pinaki, Brodsky, Leonid, Jang, Yura, Na, Chan Hyun, Qi, Yue, Zhang, Xu, Guha, Udayan, Wu, Ci, Bansal, Shivani, Ma, Junfeng, Cheema, Amrita, Albanese, Chris, Hirschey, Matthew D., Yoshida, Teruhiko, Kopp, Jeffrey B., Panov, Julia, Levi, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413283/
https://www.ncbi.nlm.nih.gov/pubmed/37429506
http://dx.doi.org/10.1016/j.jbc.2023.104975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413283/
https://www.ncbi.nlm.nih.gov/pubmed/37429506
http://dx.doi.org/10.1016/j.jbc.2023.104975

Ejemplares similares